WallStreetZenWallStreetZen

NASDAQ: WAY
Waystar Holding Corp Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for WAY

Based on 11 analysts offering 12 month price targets for Waystar Holding Corp

Min Forecast
$40.00+65.77%
Avg Forecast
$45.36+88%
Max Forecast
$54.00+123.79%

Should I buy or sell WAY stock?

Based on 11 analysts offering ratings for Waystar Holding Corp.

Strong Buy
Strong Buy
5 analysts 45.45%
Buy
5 analysts 45.45%
Hold
1 analysts 9.09%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Our proven Zen Rating quant model "Buy" agrees with analyst consensus with a "Strong Buy" rating. Learn More

Be the first to know when Wall Street analysts revise their WAY stock forecasts and price targets.

WAY stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-01-09
lockedlocked$00.00+00.00%2026-01-09
lockedlocked$00.00+00.00%2025-12-15
lockedlocked$00.00+00.00%2025-12-09
lockedlocked$00.00+00.00%2025-11-21
BMO Capital
Top 34%
67
BuyInitiates Coverage On$47.00+94.78%2025-11-13
Needham
Bottom 1%
1
BuyInitiates Coverage On$46.00+90.63%2025-11-11
Canaccord Genuity
Bottom 1%
1
Strong BuyMaintains$54.00+123.79%2025-10-30
Mizuho
Bottom 6%
6
BuyMaintains$50.00+107.21%2025-10-30
JMP Securities
Bottom 1%
1
BuyInitiates Coverage On$48.00+98.92%2025-09-18

1 of 2

Forecast return on equity

Is WAY forecast to generate an efficient return?

Company
15.47%
Industry
24.01%
Market
218.22%
WAY's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is WAY forecast to generate an efficient return on assets?

Company
10.5%
Industry
20.17%
WAY is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

WAY earnings per share forecast

What is WAY's earnings per share in the next 3 years based on estimates from 24 analysts?

Avg 1 year Forecast
$1.65+142.85%
Avg 2 year Forecast
$1.88+176.85%
Avg 3 year Forecast
$2.35+244.93%
WAY's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

WAY revenue forecast

What is WAY's revenue in the next 3 years based on estimates from 24 analysts?

Avg 1 year Forecast
$1.3B+24.63%
Avg 2 year Forecast
$1.4B+37.71%
Avg 3 year Forecast
$1.6B+52.52%
WAY's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

WAY earnings growth forecast

How is WAY forecast to perform vs Health Information Services companies and vs the US market?

Company
48.75%
Industry
34.27%
Market
40.01%
WAY's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
WAY's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
WAY's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

WAY revenue growth forecast

How is WAY forecast to perform vs Health Information Services companies and vs the US market?

Company
14.9%
Industry
10.11%
Market
22.77%
WAY's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
WAY's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

WAY vs Health Information Service Stocks

TickerPricePrice TargetUp/downsideConsensus
WAY$24.13$45.36+88.00%Strong Buy
DOCS$33.32$66.14+98.51%Buy
PRVA$21.51$30.50+41.79%Strong Buy
HNGE$31.79$63.39+99.39%Strong Buy
HQY$79.22$117.40+48.19%Buy
View Top Health Information Service Stocks

Waystar Holding Stock Forecast FAQ

Is Waystar Holding Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 11 Wall Street analysts covering (NASDAQ: WAY) stock is to Strong Buy WAY stock.

Out of 11 analysts, 5 (45.45%) are recommending WAY as a Strong Buy, 5 (45.45%) are recommending WAY as a Buy, 1 (9.09%) are recommending WAY as a Hold, 0 (0%) are recommending WAY as a Sell, and 0 (0%) are recommending WAY as a Strong Sell.

If you're new to stock investing, here's how to buy Waystar Holding stock.

What is WAY's earnings growth forecast for 2026-2028?

(NASDAQ: WAY) Waystar Holding's forecast annual earnings growth rate of 48.75% is forecast to beat the US Health Information Services industry's average forecast earnings growth rate of 34.27%, and it is also forecast to beat the US market's average forecast earnings growth rate of 40.01%.

Waystar Holding's earnings in 2026 is $111,180,000.On average, 24 Wall Street analysts forecast WAY's earnings for 2026 to be $315,940,205, with the lowest WAY earnings forecast at $268,665,878, and the highest WAY earnings forecast at $385,694,231. On average, 21 Wall Street analysts forecast WAY's earnings for 2027 to be $360,172,599, with the lowest WAY earnings forecast at $288,734,987, and the highest WAY earnings forecast at $425,870,714.

In 2028, WAY is forecast to generate $448,733,045 in earnings, with the lowest earnings forecast at $401,229,138 and the highest earnings forecast at $514,125,053.

What is WAY's revenue growth forecast for 2026-2028?

(NASDAQ: WAY) Waystar Holding's forecast annual revenue growth rate of 14.9% is forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 10.11%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 22.77%.

Waystar Holding's revenue in 2026 is $1,039,842,000.On average, 24 Wall Street analysts forecast WAY's revenue for 2026 to be $247,946,291,568, with the lowest WAY revenue forecast at $230,919,115,681, and the highest WAY revenue forecast at $262,103,718,710. On average, 22 Wall Street analysts forecast WAY's revenue for 2027 to be $273,965,346,856, with the lowest WAY revenue forecast at $260,573,186,046, and the highest WAY revenue forecast at $293,288,321,739.

In 2028, WAY is forecast to generate $303,428,100,638 in revenue, with the lowest revenue forecast at $288,122,773,998 and the highest revenue forecast at $321,794,492,606.

What is WAY's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: WAY) forecast ROA is 10.5%, which is lower than the forecast US Health Information Services industry average of 20.17%.

What is WAY's Price Target?

According to 11 Wall Street analysts that have issued a 1 year WAY price target, the average WAY price target is $45.36, with the highest WAY stock price forecast at $54.00 and the lowest WAY stock price forecast at $40.00.

On average, Wall Street analysts predict that Waystar Holding's share price could reach $45.36 by Jan 9, 2027. The average Waystar Holding stock price prediction forecasts a potential upside of 88% from the current WAY share price of $24.13.

What is WAY's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: WAY) Waystar Holding's current Earnings Per Share (EPS) is $0.68. On average, analysts forecast that WAY's EPS will be $1.65 for 2026, with the lowest EPS forecast at $1.40, and the highest EPS forecast at $2.02. On average, analysts forecast that WAY's EPS will be $1.88 for 2027, with the lowest EPS forecast at $1.51, and the highest EPS forecast at $2.23. In 2028, WAY's EPS is forecast to hit $2.35 (min: $2.10, max: $2.69).

What is WAY's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: WAY) forecast ROE is 15.47%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.